ProstaLund Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Johan Wennerholm

Chief Executive Officer (CEO)

kr2.6m

Compensación total

Porcentaje del salario del CEO	71.6%
Permanencia del CEO	3.3yrs
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	3.3yrs

Actualizaciones recientes de la dirección

Recent updates

We Think ProstaLund (STO:PLUN) Can Afford To Drive Business Growth

May 12

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Johan Wennerholm en comparación con los beneficios de ProstaLund?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-kr19m
Dec 31 2023	n/a	n/a	-kr17m
Sep 30 2023	n/a	n/a	-kr17m
Jun 30 2023	n/a	n/a	-kr13m
Mar 31 2023	n/a	n/a	-kr12m
Dec 31 2022	kr3m	kr2m	-kr11m
Sep 30 2022	n/a	n/a	-kr10m
Jun 30 2022	n/a	n/a	-kr10m
Mar 31 2022	n/a	n/a	-kr9m
Dec 31 2021	kr2m	kr2m	-kr8m

Compensación vs. Mercado: La compensación total ($USD238.24K) de Johan está en línea con el promedio de empresas de tamaño similar en el mercado Swedish ($USD238.31K).

Compensación vs. Ingresos: La compensación de Johan ha aumentado mientras la empresa no es rentable.

CEO

Johan Wennerholm (55 yo)

3.3yrs

Permanencia

kr2,588,156

Compensación

Mr. Johan Wennerholm serves as Independent Director of Inuheat Group AB (publ) from 2020. Mr. Wennerholm has been Chief Executive Officer of ProstaLund AB (publ) since January 1, 2021. He served as Chief F...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Marianne Ostlund	Independent Director	4.3yrs	kr96.60k	0.12% SEK 53.1k
Sonny Schelin	Director	12.3yrs	kr96.60k	0.093% SEK 40.3k
Mattias Lundin	Independent Chairman	3.3yrs	kr241.50k	sin datos
Mats Alyhr	Director	2yrs	kr96.60k	20.52% SEK 8.9m
Lars Johansson	Independent Director	2yrs	kr96.60k	0% SEK 0

3.3yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: La junta directiva de PLUN se considera experimentada (3.3 años de antigüedad promedio).

ProstaLund Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

ProstaLund AB (publ), Annual General Meeting, May 30, 2024

Director recently bought kr98k worth of stock

Director recently bought kr81k worth of stock

High number of new and inexperienced directors

High number of new and inexperienced directors

Insider recently bought kr229k worth of stock

Recent updates

First quarter 2024 earnings released: kr0.062 loss per share (vs kr0.056 loss in 1Q 2023)

Full year 2023 earnings released: kr0.25 loss per share (vs kr0.21 loss in FY 2022)

ProstaLund AB (publ), Annual General Meeting, May 30, 2024

New major risk - Financial position

Third quarter 2023 earnings released: kr0.082 loss per share (vs kr0.04 loss in 3Q 2022)

Second quarter 2023 earnings released: kr0.065 loss per share (vs kr0.072 loss in 2Q 2022)

Director recently bought kr98k worth of stock

ProstaLund AB (publ) Decides to Withdraw its 510(k) Application and Intend Instead to Submit a De Novo Application for Schelin Catheter® in the US

Prostalund AB (Publ) Announces Successfully Used At Asst Grande Ospedale Metropolitano Niguarda

First quarter 2023 earnings released: kr0.056 loss per share (vs kr0.042 loss in 1Q 2022)

Full year 2022 earnings released: kr0.21 loss per share (vs kr0.17 loss in FY 2021)

Director recently bought kr81k worth of stock

ProstaLund AB (publ) to Report Fiscal Year 2023 Results on Feb 16, 2024

ProstaLund Receives CE Approval Under MDR for its New Treatment Platform Coretherm® Eagle

High number of new and inexperienced directors

ProstaLund Files its 510(k) Application to the FDA for the Schelin Catheter

High number of new and inexperienced directors

Prostalund AB (Publ) Announces Coreflow® - Soft Stent - First Patient in the Uk Under Treatment

Insider recently bought kr229k worth of stock

Less than half of directors are independent

We Think ProstaLund (STO:PLUN) Can Afford To Drive Business Growth

Full year 2021 earnings released

ProstaLund Successfully Introduces Schelin Catheter as Tool

ProstaLund AB (publ) to Report Q1, 2022 Results on May 11, 2022

ProstaLund AB (publ), Annual General Meeting, May 05, 2022

ProstaLund AB (publ) Receives Utility Patent in China

Second quarter 2021 earnings released: kr0.066 loss per share (vs kr0.096 loss in 2Q 2020)

Chief Financial Officer exercised options to buy kr461k worth of stock.

Chief Financial Officer exercised options to buy kr453k worth of stock.

Prostalund Signs A Four-Year Framework Agreement with the Västra Götaland Region

New 90-day high: kr5.90

Third quarter earnings released

New 90-day high: kr3.11

New 90-day high - kr2.58

First half earnings released

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad